Shares of The Beauty Health Company (NASDAQ:SKIN – Get Free Report) have earned an average recommendation of “Hold” from the eight analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $2.02.
Several brokerages have issued reports on SKIN. Roth Capital restated a “buy” rating and set a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a report on Monday, July 20th. Canaccord Genuity Group lowered their price objective on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Friday, May 1st. Finally, Weiss Ratings lowered Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday.
Read Our Latest Stock Analysis on Beauty Health
Beauty Health Trading Down 1.1%
Beauty Health (NASDAQ:SKIN – Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The business had revenue of $64.91 million during the quarter, compared to analyst estimates of $66.28 million. Equities analysts forecast that Beauty Health will post -0.16 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Beauty Health
A number of large investors have recently modified their holdings of SKIN. Invesco Ltd. increased its holdings in Beauty Health by 6.6% in the second quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock valued at $188,000 after buying an additional 6,059 shares during the last quarter. Rhumbline Advisers lifted its stake in Beauty Health by 5.7% during the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock worth $299,000 after purchasing an additional 8,142 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in Beauty Health by 33.5% in the second quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock valued at $79,000 after purchasing an additional 10,410 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in Beauty Health in the third quarter valued at approximately $26,000. Finally, SG Americas Securities LLC increased its stake in Beauty Health by 111.9% in the fourth quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock valued at $34,000 after purchasing an additional 13,026 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.
About Beauty Health
Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.
Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.
Read More
- Five stocks we like better than Beauty Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
